FutureFuel’s debt-free balance sheet and Batesville asset base support a cyclical recovery, but policy-dependent biodiesel economics leave its five-year upside highly asymmetric.
Overview
FutureFuel Corp. is a micro-cap manufacturer of custom and performance specialty chemicals and biomass-based diesel, operating virtually all production from a 2,200-acre integrated site in Batesville, Arkansas. Chemicals serves agricultural protection, polymers, energy services, cleaning, and pharmaceutical intermediates; Biofuels has approximately 59 million gallons per year of biodiesel capacity. The site’s rail, barge, pipeline, utility, and waste-treatment infrastructure creates a meaningful operating barrier, while custom chemical qualification can make customer relationships sticky. **Q2 2026 marked a sharp operating recovery:** revenue rose 120.7% year over year to $78.73 million, GAAP net income was $11.37 million, diluted EPS was $0.25, and Adjusted EBITDA was $11.82 million. Still, first-half net loss was $9.21 million, and Q2 gross profit included inventory and derivative timing benefits. Management reaffirmed positive full-year 2026 Adjusted EBITDA, excluding non-cash derivative and inventory adjustments. The balance sheet had $34.37 million cash, no long-term debt, and $35 million of undrawn revolver capacity. At $5.12, shares traded at 1.46x TTM sales and 1.24x EV/sales. The five-year probability-weighted target is $7.58, but outcomes hinge on policy, spreads, and execution; near-term catalysts include $22 million of 45Z credit proceeds and sustained plant utilization.